buflomedil vs placebo | No demonstrated result suggested cardiovascular events by 26% (not demonstrated) | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
cardiovascular events | 0.74 [0.56 0.98] | p=0.04 | 0 | 2078 | 1 | LIMB, | Cardiovascular death | 0.76 [0.48 1.18] | p=1.00 | 0 | 2078 | 1 | LIMB, | myocardial infarction (fatal and non fatal) | 0.90 [0.39 2.09] | p=1.00 | 0 | 2118 | 2 | LIMB,Diamantopoulos, | stroke (fatal and non fatal) | 1.17 [0.52 2.63] | p=1.00 | 0 | 2078 | 1 | LIMB, | Revascularization | no data | All cause death | 0.88 [0.63 1.23] | p=1.00 | 0 | 2118 | 2 | LIMB,Diamantopoulos, | Treatment related complication | 0.93 [0.76 1.15] | p=1.00 | 0 | 2078 | 1 | LIMB, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |